HistoSonics gets FDA approval of trial for kidney tumor treatment device
ANN ARBOR–HistoSonics, developers of non-invasive sonic beam therapy called histotripsy, announced that the U.S. Food and Drug Administration has approved the company sponsored #HOPE4KIDNEY Trial, which is designed to evaluate the …